Enova Reports Fourth Quarter and Full Year 2022 Results
Enova International (NYSE: ENVA) reported strong financial results for Q4 2022, achieving total revenue of $486 million, a 34% increase from the prior year. Net income was $51 million, or $1.56 per diluted share. For the full year, total revenue reached $1.736 billion, up 44% from $1.208 billion in 2021. However, net revenue margin decreased from 85% in 2021 to 64% in 2022. Originations totaled $1.2 billion, reflecting a 9% year-over-year increase. The company ended the year with a robust liquidity position of $729 million and reported a consolidated portfolio net charge-off rate of 8.8%.
- Total revenue increased 34% year-over-year to $486 million in Q4 2022.
- Net income for Q4 2022 reached $51 million, an increase from $49 million in Q4 2021.
- Total revenue for the full year 2022 was $1.736 billion, up 44% from 2021.
- Originations rose by 9%, totaling $1.2 billion in Q4 2022.
- Liquidity at year-end was $729 million, providing financial flexibility.
- Net revenue margin decreased from 85% in 2021 to 64% in 2022.
- Adjusted earnings per diluted share declined from $7.57 in 2021 to $6.81 in 2022.
- Total revenue increased
7% sequentially and34% from the fourth quarter of 2021 to$486 million - Strong profitability with diluted earnings per share of
and adjusted earnings per share of$1.56 $1.76 - Total company originations were
,$1.2 billion 9% higher than originations for the fourth quarter of 2021, and total receivables, on an amortized basis, increased46% from year-end 2021 to$2.9 billion - Continued solid credit performance and outlook with a fourth quarter net revenue margin of
60% , total consolidated portfolio net charge-offs as a percentage of average combined loan and finance receivables of8.8% for the fourth quarter and an increase in the fair value of the consolidated portfolio as a percentage of principal to110% atDecember 31 - At year-end 2022, total liquidity was
, including cash and marketable securities of$729 million and available capacity on revolving facilities of$196 million $533 million
"Looking back on 2022, our team executed remarkably well in an evolving macro environment by delivering meaningful growth while effectively managing risk," said
Fourth Quarter 2022 Summary
- Total revenue of
in the fourth quarter of 2022 increased$486 million 34% from in the fourth quarter of 2021.$364 million - Net revenue margin of
60% in the fourth quarter of 2022 compared to77% in the fourth quarter of 2021. - Net income attributable to
Enova International, Inc. of , or$51 million per diluted share, in the fourth quarter of 2022 compared to$1.56 , or$49 million per diluted share, in the fourth quarter of 2021.$1.30 - Fourth quarter 2022 adjusted EBITDA, a non-GAAP measure, of
compared to$120 million in the fourth quarter of 2021.$101 million - Adjusted earnings of
, or$57 million per diluted share, both non-GAAP measures, in the fourth quarter of 2022 compared to adjusted earnings of$1.76 , or$60 million per diluted share, in the fourth quarter of 2021.$1.61
Full Year 2022 Summary
- Total revenue of
in 2022 increased$1.73 6 billion44% from in 2021.$1.20 8 billion - Net revenue margin of
64% in 2022 compared to85% in 2021. - Net income from continuing operations of
, or$207 million per diluted share, in 2022, compared to$6.19 , or$256 million per diluted share, in 2021.$6.79 - Full year 2022 adjusted EBITDA of
, a non-GAAP measure, compared to$443 million in 2021.$473 million - Adjusted earnings of
, or$228 million per diluted share, both non-GAAP measures, in 2022, compared to adjusted earnings of$6.81 , or$286 million per diluted share, in 2021.$7.57
"We are pleased to end 2022 with another quarter of solid top- and bottom-line financial performance that was in line with our expectations," said
For information regarding the non-GAAP financial measures discussed in this release, please see "Non-GAAP Financial Measures" and "Reconciliation of GAAP to Non-GAAP Financial Measures" below.
Conference Call
Enova will host a conference call to discuss its fourth quarter and full year 2022 results at 4 p.m. Central Time / 5 p.m. Eastern Time today,
About Enova
Cautionary Statement Concerning Forward Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about the business, financial condition and prospects of Enova. These forward-looking statements give current expectations or forecasts of future events and reflect the views and assumptions of Enova's senior management with respect to the business, financial condition and prospects of Enova as of the date of this release and are not guarantees of future performance. The actual results of Enova could differ materially from those indicated by such forward-looking statements because of various risks and uncertainties applicable to Enova's business, including, without limitation, those risks and uncertainties indicated in Enova's filings with the
Non-GAAP Financial Measures
In addition to the financial information prepared in conformity with generally accepted accounting principles, or GAAP, Enova provides historical non-GAAP financial information. Management believes that presentation of non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of Enova's operations. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of Enova's business that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.
Management provides non-GAAP financial information for informational purposes and to enhance understanding of Enova's GAAP consolidated financial statements. Readers should consider the information in addition to, but not instead of or superior to, Enova's financial statements prepared in accordance with GAAP. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes.
Combined Loans and Finance Receivables
The combined loans and finance receivables measures are non-GAAP measures that include loans and finance receivables that Enova owns or has purchased and loans that Enova guarantees. Management believes these non-GAAP measures provide investors with important information needed to evaluate the magnitude of potential receivable losses and the opportunity for revenue performance of the loans and finance receivable portfolio on an aggregate basis. Management also believes that the comparison of the aggregate amounts from period to period is more meaningful than comparing only the amounts reflected on Enova's consolidated balance sheet since revenue is impacted by the aggregate amount of receivables owned by Enova and those guaranteed by Enova as reflected in its consolidated financial statements.
Adjusted Earnings Measures
In addition to reporting financial results in accordance with GAAP, Enova has provided adjusted earnings and adjusted earnings per share, or, collectively, the Adjusted Earnings Measures, which are non-GAAP measures. Management believes that the presentation of these measures provides investors with greater transparency and facilitates comparison of operating results across a broad spectrum of companies with varying capital structures, compensation strategies, derivative instruments and amortization methods, which provides a more complete understanding of Enova's financial performance, competitive position and prospects for the future. Management also believes that investors regularly rely on non-GAAP financial measures, such as the Adjusted Earnings Measures, to assess operating performance and that such measures may highlight trends in Enova's business that may not otherwise be apparent when relying on financial measures calculated in accordance with GAAP. In addition, management believes that the adjustments shown below are useful to investors in order to allow them to compare Enova's financial results during the periods shown without the effect of each of these expense items.
Adjusted EBITDA Measures
In addition to reporting financial results in accordance with GAAP, Enova has provided Adjusted EBITDA and Adjusted EBITDA margin, or, collectively, the Adjusted EBITDA measures, which are non-GAAP measures. Adjusted EBITDA is a non-GAAP measure that Enova defines as earnings excluding depreciation, amortization, interest, foreign currency transaction gains or losses, taxes and stock-based compensation. In addition, management believes that the adjustments for transaction-related costs, lease termination and cease-use costs, other nonoperating expenses and equity method investment income shown below are useful to investors in order to allow them to compare our financial results during the periods shown without the effect of the expense items. Adjusted EBITDA margin is a non-GAAP measure that Enova defines as Adjusted EBITDA as a percentage of total revenue. Management believes Adjusted EBITDA Measures are used by investors to analyze operating performance and evaluate Enova's ability to incur and service debt and Enova's capacity for making capital expenditures. Adjusted EBITDA Measures are also useful to investors to help assess Enova's estimated enterprise value.
| ||||||||
2022 | 2021 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 100,165 | $ | 165,477 | ||||
Restricted cash | 78,235 | 60,406 | ||||||
Loans and finance receivables at fair value | 3,018,528 | 1,964,690 | ||||||
Income taxes receivable | 43,741 | 51,104 | ||||||
Other receivables and prepaid expenses | 66,267 | 52,274 | ||||||
Property and equipment, net | 93,228 | 78,402 | ||||||
Operating lease right-of-use asset | 19,347 | 23,101 | ||||||
279,275 | 279,275 | |||||||
Intangible assets, net | 27,390 | 35,444 | ||||||
Other assets | 54,713 | 51,310 | ||||||
Total assets | $ | 3,780,889 | $ | 2,761,483 | ||||
Liabilities and Stockholders' Equity | ||||||||
Accounts payable and accrued expenses | $ | 198,320 | $ | 156,102 | ||||
Operating lease liability | 33,595 | 40,987 | ||||||
Deferred tax liabilities, net | 104,169 | 86,943 | ||||||
Long-term debt | 2,258,660 | 1,384,399 | ||||||
Total liabilities | 2,594,744 | 1,668,431 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity: | ||||||||
Common stock, | — | — | ||||||
Preferred stock, | — | — | ||||||
Additional paid in capital | 251,878 | 225,689 | ||||||
Retained earnings | 1,313,185 | 1,105,761 | ||||||
Accumulated other comprehensive loss | (5,990) | (8,540) | ||||||
(372,928) | (229,858) | |||||||
Total stockholders' equity | 1,186,145 | 1,093,052 | ||||||
Total liabilities and stockholders' equity | $ | 3,780,889 | $ | 2,761,483 |
| ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenue | $ | 486,164 | $ | 363,608 | $ | 1,736,085 | $ | 1,207,932 | ||||||||
Change in Fair Value | (196,056) | (83,229) | (618,521) | (183,672) | ||||||||||||
Net Revenue | 290,108 | 280,379 | 1,117,564 | 1,024,260 | ||||||||||||
Operating Expenses | ||||||||||||||||
Marketing | 96,573 | 107,612 | 382,573 | 271,160 | ||||||||||||
Operations and technology | 44,723 | 39,072 | 173,668 | 147,700 | ||||||||||||
General and administrative | 35,064 | 40,641 | 140,464 | 156,962 | ||||||||||||
Depreciation and amortization | 8,499 | 12,374 | 36,867 | 35,375 | ||||||||||||
Total Operating Expenses | 184,859 | 199,699 | 733,572 | 611,197 | ||||||||||||
Income from Operations | 105,249 | 80,680 | 383,992 | 413,063 | ||||||||||||
Interest expense, net | (37,530) | (19,016) | (115,887) | (76,509) | ||||||||||||
Foreign currency transaction (loss) gain, net | (715) | 1 | (645) | (382) | ||||||||||||
Equity method investment (loss) income | (87) | 395 | 6,435 | 2,953 | ||||||||||||
Other nonoperating expenses | — | (842) | (1,321) | (1,970) | ||||||||||||
Income before Income Taxes | 66,917 | 61,218 | 272,574 | 337,155 | ||||||||||||
Provision for income taxes | 16,045 | 12,480 | 65,150 | 80,087 | ||||||||||||
Net income before noncontrolling interest | 50,872 | 48,738 | 207,424 | 257,068 | ||||||||||||
Less: Net income attributable to noncontrolling interest | — | 88 | — | 773 | ||||||||||||
Net income attributable to | $ | 50,872 | $ | 48,650 | $ | 207,424 | $ | 256,295 | ||||||||
Earnings Per Share attributable to | ||||||||||||||||
Earnings per common share: | ||||||||||||||||
Basic | $ | 1.62 | $ | 1.36 | $ | 6.42 | $ | 7.05 | ||||||||
Diluted | $ | 1.56 | $ | 1.30 | $ | 6.19 | $ | 6.79 | ||||||||
Weighted average common shares outstanding: | ||||||||||||||||
Basic | 31,401 | 35,750 | 32,290 | 36,351 | ||||||||||||
Diluted | 32,627 | 37,330 | 33,483 | 37,736 |
| ||||||||
Year Ended | ||||||||
2022 | 2021 | |||||||
Cash flows provided by operating activities | 893,998 | 471,868 | ||||||
Cash flows from investing activities | ||||||||
Loans and finance receivables | (1,631,354) | (923,494) | ||||||
Acquisitions, net of cash acquired | — | (29,153) | ||||||
Property and equipment additions | (43,629) | (29,674) | ||||||
Sale of subsidiary | 8,713 | 1,928 | ||||||
Other investing activities | — | 25 | ||||||
Total cash flows used in investing activities | (1,666,270) | (980,368) | ||||||
Cash flows provided by financing activities | 724,866 | 365,149 | ||||||
Effect of exchange rates on cash | (77) | 34 | ||||||
Net decrease in cash and cash equivalents and restricted cash | (47,483) | (143,317) | ||||||
Cash, cash equivalents and restricted cash at beginning of year | 225,883 | 369,200 | ||||||
Cash, cash equivalents and restricted cash at end of period | $ | 178,400 | $ | 225,883 |
| ||||||||||||
The following table includes financial information for loans and finance receivables, which is based on loan and finance receivable balances for the three months ended | ||||||||||||
Three Months Ended | 2022 | 2021 | Change | |||||||||
Ending combined loan and finance receivable principal balance: | ||||||||||||
Company owned | $ | 2,739,164 | $ | 1,878,426 | $ | 860,738 | ||||||
Guaranteed by the Company(a) | 12,937 | 11,790 | 1,147 | |||||||||
Total combined loan and finance receivable principal balance(b) | $ | 2,752,101 | $ | 1,890,216 | $ | 861,885 | ||||||
Ending combined loan and finance receivable fair value balance: | ||||||||||||
Company owned | $ | 3,018,528 | $ | 1,964,690 | $ | 1,053,838 | ||||||
Guaranteed by the Company(a) | 16,257 | 18,813 | (2,556) | |||||||||
Ending combined loan and finance receivable fair value balance(b) | $ | 3,034,785 | $ | 1,983,503 | $ | 1,051,282 | ||||||
Fair value as a % of principal(c) | 110.3 | % | 104.9 | % | 5.4 | % | ||||||
Ending combined loan and finance receivable balance, including principal and accrued fees/interest outstanding: | ||||||||||||
Company owned | $ | 2,837,799 | $ | 1,944,263 | $ | 893,536 | ||||||
Guaranteed by the Company(a) | 15,644 | 13,750 | 1,894 | |||||||||
Ending combined loan and finance receivable balance(b) | $ | 2,853,443 | $ | 1,958,013 | $ | 895,430 | ||||||
Average combined loan and finance receivable balance, including principal and accrued fees/interest outstanding: | ||||||||||||
Company owned(d) | $ | 2,723,006 | $ | 1,792,257 | $ | 930,749 | ||||||
Guaranteed by the Company(a)(d) | 15,050 | 13,212 | 1,838 | |||||||||
Average combined loan and finance receivable balance(a)(d) | $ | 2,738,056 | $ | 1,805,469 | $ | 932,587 | ||||||
Revenue | $ | 478,945 | $ | 358,633 | $ | 120,312 | ||||||
Change in fair value | (194,375) | (81,911) | (112,464) | |||||||||
Net revenue | 284,570 | 276,722 | 7,848 | |||||||||
Net revenue margin | 59.4 | % | 77.2 | % | (17.8) | % | ||||||
Change in fair value as a % of average loan and finance receivable balance(d) | 7.1 | % | 4.5 | % | 2.6 | % | ||||||
Delinquencies: | ||||||||||||
>30 days delinquent | $ | 190,119 | $ | 103,213 | $ | 86,906 | ||||||
>30 days delinquent as a % of loan and finance receivable balance(c) | 6.7 | % | 5.3 | % | 1.4 | % | ||||||
Charge-offs: | ||||||||||||
Charge-offs (net of recoveries) | $ | 240,531 | $ | 120,259 | $ | 120,272 | ||||||
Charge-offs (net of recoveries) as a % of average loan and finance receivable balance(d) | 8.8 | % | 6.7 | % | 2.1 | % |
(a) | Represents loans originated by third-party lenders through the CSO programs, which are not included in our consolidated balance sheets. | ||||
(b) | Non-GAAP measure. | ||||
(c) | Determined using period-end balances. | ||||
(d) | The average combined loan and finance receivable balance is the average of the month-end balances during the period. |
| ||||||||||||||||
Adjusted Earnings Measures | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net income | $ | 50,872 | $ | 48,650 | $ | 207,424 | $ | 256,295 | ||||||||
Adjustments: | ||||||||||||||||
Transaction-related costs(a) | — | — | — | 1,424 | ||||||||||||
Lease termination and cease use costs(b) | — | 7,648 | — | 7,535 | ||||||||||||
Equity method investment loss (income)(c) | 87 | — | (6,107) | — | ||||||||||||
Other nonoperating expenses(d) | — | 842 | 1,321 | 1,970 | ||||||||||||
Intangible asset amortization | 2,014 | 2,014 | 8,055 | 6,862 | ||||||||||||
Stock-based compensation expense | 5,993 | 5,107 | 21,950 | 21,179 | ||||||||||||
Foreign currency transaction loss (gain), net | 715 | (1) | 645 | 372 | ||||||||||||
Cumulative tax effect of adjustments | (2,191) | (4,012) | (5,365) | (9,855) | ||||||||||||
Adjusted earnings | $ | 57,490 | $ | 60,248 | $ | 227,923 | $ | 285,782 | ||||||||
Diluted earnings per share | $ | 1.56 | $ | 1.30 | $ | 6.19 | $ | 6.79 | ||||||||
Adjusted earnings per share | $ | 1.76 | $ | 1.61 | $ | 6.81 | $ | 7.57 | ||||||||
Adjusted EBITDA | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Net income | $ | 50,872 | $ | 48,650 | $ | 207,424 | $ | 256,295 | ||||||||
Depreciation and amortization expenses(e) | 8,499 | 12,372 | 36,867 | 35,362 | ||||||||||||
Interest expense, net(e) | 37,530 | 18,916 | 115,887 | 75,929 | ||||||||||||
Foreign currency transaction loss (gain), net(e) | 715 | (1) | 645 | 372 | ||||||||||||
Provision for income taxes | 16,045 | 12,480 | 65,150 | 80,087 | ||||||||||||
Stock-based compensation expense | 5,993 | 5,107 | 21,950 | 21,179 | ||||||||||||
Adjustments: | ||||||||||||||||
Transaction-related costs(a) | — | — | — | 1,424 | ||||||||||||
Lease termination and cease use loss(b) | — | 3,449 | — | 3,336 | ||||||||||||
Equity method investment loss (income)(c) | 87 | (395) | (6,435) | (2,953) | ||||||||||||
Other nonoperating expenses(d) | — | 842 | 1,321 | 1,970 | ||||||||||||
Adjusted EBITDA | $ | 119,741 | $ | 101,420 | $ | 442,809 | $ | 473,001 | ||||||||
Adjusted EBITDA margin calculated as follows: | ||||||||||||||||
Total Revenue | $ | 486,164 | $ | 363,608 | $ | 1,736,085 | $ | 1,207,932 | ||||||||
Adjusted EBITDA | 119,741 | 101,420 | 442,809 | 473,001 | ||||||||||||
Adjusted EBITDA as a percentage of total revenue | 24.6 | % | 27.9 | % | 25.5 | % | 39.2 | % |
(a) | In the first quarter of 2021, the Company incurred expenses totaling | ||||
(b) | In the fourth and third quarters of 2021, the Company recorded a loss of | ||||
(c) | In the second quarter of 2022, the Company recorded a gain of | ||||
(d) | In the fourth quarter of 2021, the Company incurred a loss of | ||||
(e) | Excludes amounts attributable to noncontrolling interests. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/enova-reports-fourth-quarter-and-full-year-2022-results-301736426.html
SOURCE
FAQ
What are Enova's Q4 2022 earnings results?
How did Enova's revenue for 2022 compare to 2021?
What was Enova's net revenue margin in Q4 2022?
What was the originations figure for Enova in Q4 2022?